The design of new molecules possessing potential biological activity is important area of research. Thiadiazole is a versatile moiety that exhibits a wide variety of biological activities since it acts as a constrained pharmacophore in many drugs such as acetazolamide, methazolamide, sulfamethazole, etc., In this context, a series of 2,5,6 imidazo[2,1-b][1,3,4]thiadiazole derivatives with various structural features were designed. The derivatives were found to exhibit cytotoxic activity against human cervix carcinoma as well as murine leukemia cells. Further, combined crystal structure and the structure activity relationship studies (SAR) indicated that, formyl and thiocyanate substituents at C5 resulted good cytotoxic activity against several tumor cell lines, which was superior to standard anti-tumor drugs such as melphalan or Levamisole [1]. Substitution of bromine at C-5 position did not produce any improvement in cytotoxicity activity. The crystal structure investigation of series of 2,5,6-substituted imidazo[2,1-b][1,3,4]thiadiazoles has been carried out to understand the influence of various substituents especially halogens on the conformation of imidazo thiadiazole moiety.
